DE60003214D1 - Benz[f]indole zur verwendung in der behandlung von 5ht-rezeptor relatierten störungen - Google Patents

Benz[f]indole zur verwendung in der behandlung von 5ht-rezeptor relatierten störungen

Info

Publication number
DE60003214D1
DE60003214D1 DE60003214T DE60003214T DE60003214D1 DE 60003214 D1 DE60003214 D1 DE 60003214D1 DE 60003214 T DE60003214 T DE 60003214T DE 60003214 T DE60003214 T DE 60003214T DE 60003214 D1 DE60003214 D1 DE 60003214D1
Authority
DE
Germany
Prior art keywords
benz
indole
treating
receptor related
related interference
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60003214T
Other languages
English (en)
Other versions
DE60003214T2 (de
Inventor
Laramie Mary Gaster
Thomas Daniel Heightman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of DE60003214D1 publication Critical patent/DE60003214D1/de
Application granted granted Critical
Publication of DE60003214T2 publication Critical patent/DE60003214T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60003214T 1999-11-05 2000-11-02 Benz[f]indole zur verwendung in der behandlung von 5ht-rezeptor relatierten störungen Expired - Fee Related DE60003214T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9926301.4A GB9926301D0 (en) 1999-11-05 1999-11-05 Novel compounds
GB9926301 1999-11-05
PCT/EP2000/010913 WO2001032647A2 (en) 1999-11-05 2000-11-02 Benz`f!indoles for use in the treatment of 5ht receptor related disorders

Publications (2)

Publication Number Publication Date
DE60003214D1 true DE60003214D1 (de) 2003-07-10
DE60003214T2 DE60003214T2 (de) 2004-04-29

Family

ID=10864070

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60003214T Expired - Fee Related DE60003214T2 (de) 1999-11-05 2000-11-02 Benz[f]indole zur verwendung in der behandlung von 5ht-rezeptor relatierten störungen

Country Status (7)

Country Link
EP (1) EP1226120B1 (de)
JP (1) JP2003513086A (de)
AT (1) ATE242212T1 (de)
DE (1) DE60003214T2 (de)
ES (1) ES2199888T3 (de)
GB (1) GB9926301D0 (de)
WO (1) WO2001032647A2 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6391894A (en) * 1993-03-16 1994-10-11 Pfizer Inc. Naphthalene derivatives

Also Published As

Publication number Publication date
ES2199888T3 (es) 2004-03-01
EP1226120B1 (de) 2003-06-04
EP1226120A2 (de) 2002-07-31
JP2003513086A (ja) 2003-04-08
WO2001032647A3 (en) 2001-12-13
ATE242212T1 (de) 2003-06-15
DE60003214T2 (de) 2004-04-29
WO2001032647A2 (en) 2001-05-10
GB9926301D0 (en) 2000-01-12

Similar Documents

Publication Publication Date Title
ATE396722T1 (de) Kleine moleküle zur behandlung von endzündlichen erkrankungen
ATE265456T1 (de) 2-amino-6-anilino-purine und deren verwendung als arzneimittel
TR200003206T2 (tr) İndol türevleri ve patolojik hücre çoğalmasının neden olduğu habis hastalıklar ve diğer hastalıkların tedavisinde kullanımları.
DE69909818D1 (de) Pyrazolopyimidinon-derivate zur behandlung von impotenz
MY133732A (en) Sulfonylcarboxamide derivatives, process for their preparation and their use as medicines
ATE370139T1 (de) Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs
ATE269303T1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE326466T1 (de) Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
ATE260653T1 (de) Verwendung von naaladase inhibitoren zur behandlung von angstzuständen und gedächtnisstörungen
ATE275400T1 (de) Verwendung von melatonin zur behandlung der androgenetischen und diffusen alopezie vom weiblichen typ
ATE302002T1 (de) Verwendung von pyrazolderivaten zur behandlung von unfruchtbarkeit
ATE255094T1 (de) Piperazinderivate zur behandlung der niedrigen harnwege
BR9811348A (pt) Compostos derivados de indol, processo para preparação dos mesmos, e, composições farmacêuticas.
ATE290857T1 (de) Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen
DE69916488D1 (de) Substituierte caprolactam-derivate, diese enthaltende pharmazeutische zubereitungen sowie ihre verwendung zur behandlung von tumoren
DE60003214D1 (de) Benz[f]indole zur verwendung in der behandlung von 5ht-rezeptor relatierten störungen
DE60010934D1 (de) Medikamente geeignet zur Behandlung von proliferativen Erkrankungen
BRPI0410026A (pt) derivados de 3-amino-croman quinolina
YU19302A (sh) 4-benzilaminohinolin konjugovan žučnom kiselinom i njegovi heteroanalozi, postupak za njihovu proizvodnju, lekovi koji sadrže ta jedinjenja i njihova primena
ATE319709T1 (de) Indolderivate zur behandlung von depression und angstzuständen
DE60009315D1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
ATE229953T1 (de) Naphtho-imidazo(1,2-a)pyridin derivate, deren herstellung und deren verwendung in der behandlung von störungen des zentralnervensystems
MXPA04001977A (es) Antagonistas v de receptor ccr-3.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee